The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort

INTRODUCTION: Hydroxychloroquine (HCQ) is an antimalarial drug that received worldwide news and media attention in the treatment of patients with coronavirus disease 2019 (COVID-19). This drug was used on the basis of its antimicrobial and antiviral properties despite lack of definite evidence of cl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Infect Dis Ther
Egile Nagusiak: Abdulrahman, Abdulkarim, AlSayed, Islam, AlMadhi, Marwa, AlArayed, Jumana, Mohammed, Sara Jaafar, Sharif, Aesha Khalid, Alansari, Khadija, AlAwadhi, Abdulla Ismael, AlQahtani, Manaf
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2021
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7822757/
https://ncbi.nlm.nih.gov/pubmed/33484407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-021-00397-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak